ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105509 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105509; 2) Community: the network communities that were significantly associated with the response to NSC 105509; 3) Molecule: the relationships between components within communities and NSC 105509; 4) MDR: the compounds that were significantly associated with the NSC 105509.

NSC Compound Enrichment Correlation
NSC 762914 6-(4-hydroxy-2-methylphenyl)-2-(4-(methylsulfonyl)phenyl)-4,5-dihydropyridazin-3(2H)-one 0.00264567501902517 -0.18034219
NSC 751605 (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide 0.00289834947687855 -0.23943465
NSC 111702 p-Dioxane-2-methanol, 3,5-dihydroxy-6-[6-(methylthio)-9H-purin-9-yl]- 0.00313644776247638 -0.14947644
NSC 3088 Chlorambucil 0.00313644776247638 0.003231673
NSC 610459 Camptothecin Derivative 0.00313644776247638 0.043741947
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.00313644776247638 0.11515764
NSC 671174 Null 0.00313644776247638 -0.18268993
NSC 693773 Null 0.00313644776247638 0.3749665
NSC 93739 Aizen Magenta 0.00313644776247638 0.25382837
NSC 681271 1,3,6-Triphenyl-oxazolo(5,4-d)pyrimidin-2',4(1H,3H)-dion 0.00347157511980527 0.5112843
Total:57  Current:5    [First] [Prev] [Next] [Last]